Temasek CEO: AI can have “profound impact” on pharma and biotech #shorts #bloomberginvest

Temasek CEO Dilhan Pillay Sandrasegara says AI will not eliminate the need for software during a discussion with Bloomberg’s Lisa Abramowicz at #BloombergInvest https://bloom.bg/4soHwd8